University of Virginia at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Virginia brings 9 presentations to ASH 2026 in New Orleans. Its research centres on large granular lymphocyte leukemia and its STAT3 mutations. Work also covers azacitidine effects, an AI-derived gene signature and a combination trial in acute myeloid leukemia.
| Organization | ASH 2026 Attendance |
|---|---|
University of Virginia Charlottesville, VA | |
Public research university in Charlottesville, Virginia, with a medical school and the UVA Health system. | Talk Sat Dec 12 9:30am–11:00am Session Sat Dec 12 9:30am–11:00am QI Intensive - A Practical Guide to Quality Improvement in Hematology Quality improvement methods for hematology practice, from spotting care gaps and writing aim statements to choosing measures that show real change. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 12:00pm–1:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University of Virginia
Tell us what you sell and we’ll find the people at University of Virginia most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction